NT 10-Q

FORM 12B-25

Company: Processa Pharmaceuticals, Inc.
Filed: November 16, 2015
Period of Report: September 30, 2015
Accession Number: 0001393905-15-000605

View Document ↗ View on SEC.gov ↗